Diba Emal

757 total citations
7 papers, 310 citations indexed

About

Diba Emal is a scholar working on Immunology, Molecular Biology and Nephrology. According to data from OpenAlex, Diba Emal has authored 7 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Diba Emal's work include Immune Response and Inflammation (3 papers), Inflammasome and immune disorders (2 papers) and Dialysis and Renal Disease Management (1 paper). Diba Emal is often cited by papers focused on Immune Response and Inflammation (3 papers), Inflammasome and immune disorders (2 papers) and Dialysis and Renal Disease Management (1 paper). Diba Emal collaborates with scholars based in Netherlands, France and Canada. Diba Emal's co-authors include Sandrine Florquin, Mark C. Dessing, Gwendoline J.D. Teske, Marcel P.B. Jansen, Joris J. T. H. Roelofs, Nike Claessen, Jaklien C. Leemans, Elena Rampanelli, Ingrid Stroo and Loes M. Butter and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Kidney International.

In The Last Decade

Diba Emal

7 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diba Emal Netherlands 6 126 103 102 48 41 7 310
P. Gollapudi United States 7 125 1.0× 51 0.5× 112 1.1× 61 1.3× 53 1.3× 9 369
Johanna T. Kurzhagen United States 10 80 0.6× 85 0.8× 156 1.5× 30 0.6× 42 1.0× 13 343
Franziska Kraft Germany 5 184 1.5× 103 1.0× 102 1.0× 28 0.6× 31 0.8× 5 340
Zbigniew Hruby Poland 9 56 0.4× 62 0.6× 112 1.1× 38 0.8× 50 1.2× 32 282
Cassandra L. Formeck United States 6 87 0.7× 43 0.4× 123 1.2× 47 1.0× 30 0.7× 8 234
Paul H. Baehr United States 4 25 0.2× 73 0.7× 108 1.1× 66 1.4× 81 2.0× 5 328
Yini Sun China 10 140 1.1× 75 0.7× 15 0.1× 98 2.0× 25 0.6× 33 303
Takeshi Tana Japan 11 83 0.7× 119 1.2× 82 0.8× 81 1.7× 44 1.1× 26 415
Marcelino de Souza Durão Brazil 10 19 0.2× 87 0.8× 140 1.4× 52 1.1× 95 2.3× 35 333
Marjan Afrouzian United States 10 133 1.1× 46 0.4× 35 0.3× 44 0.9× 142 3.5× 21 396

Countries citing papers authored by Diba Emal

Since Specialization
Citations

This map shows the geographic impact of Diba Emal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diba Emal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diba Emal more than expected).

Fields of papers citing papers by Diba Emal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diba Emal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diba Emal. The network helps show where Diba Emal may publish in the future.

Co-authorship network of co-authors of Diba Emal

This figure shows the co-authorship network connecting the top 25 collaborators of Diba Emal. A scholar is included among the top collaborators of Diba Emal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diba Emal. Diba Emal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Emal, Diba, Elena Rampanelli, Nike Claessen, et al.. (2019). Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection. Scientific Reports. 9(1). 106–106. 26 indexed citations
2.
Stroo, Ingrid, Diba Emal, Loes M. Butter, et al.. (2018). No difference in renal injury and fibrosis between wild-type and NOD1/NOD2 double knockout mice with chronic kidney disease induced by ureteral obstruction. BMC Nephrology. 19(1). 78–78. 6 indexed citations
3.
Tammaro, Alessandra, Jesper Kers, Diba Emal, et al.. (2016). Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation. Scientific Reports. 6(1). 38275–38275. 28 indexed citations
4.
Lissenberg‐Thunnissen, Suzanne N., et al.. (2016). Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells. Inflammation Research. 65(6). 449–458. 6 indexed citations
5.
Jansen, Marcel P.B., Diba Emal, Gwendoline J.D. Teske, et al.. (2016). Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney International. 91(2). 352–364. 137 indexed citations
6.
Emal, Diba, Elena Rampanelli, Ingrid Stroo, et al.. (2016). Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology. 28(5). 1450–1461. 105 indexed citations
7.
Verbrugge, Sue Ellen, Diba Emal, Sinéad M. Lougheed, et al.. (2012). Targeting the immunoproteasome with the second generation proteasome inhibitor ONX 0914: effects on IFN-alpha-induced monocyte-derived dendritic cells (119.4). The Journal of Immunology. 188(1_Supplement). 119.4–119.4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026